You are here

Celladon

6 BioHealth Movers That Now Cannot Be Ignored

24/7 Wall St

Sun, 11/22/15 - 01:33 pm

Clovis Oncology

Sarepta Therapeutics

Valeant Pharmaceuticals

The top 10 biopharma pipeline disasters of 2015

Fierce Biotech

Fri, 10/30/15 - 09:55 am

Celladon pulls the plug on R&D after a crushing gene therapy failure

Fierce Biotech

Fri, 06/26/15 - 11:53 am

Celladon halves its workforce to conserve cash after gene therapy meltdown

Fierce Biotech

Fri, 05/15/15 - 09:35 am

Celladon's stock craters after disappointing trial results, downgrade

Marketwatch

Mon, 04/27/15 - 10:01 am

Could This Clinical-Stage Biotech Stock Soar in April?

Motley Fool

Thu, 03/12/15 - 11:24 am

Celladon's Mydicar candidate granted breakthrough therapy designation by FDA

The Fly on the Wall

Thu, 04/10/14 - 10:39 am

breakthrough therapies

Gene Therapy's Big Comeback

Forbes

Wed, 03/26/14 - 08:07 am

Bristol-Myers Squibb

Voyager Therapeutics

Juno Therapeutics

Editas Medicine

Gensight Biologics

Audentes Therapeutics

Dimension Therapeutics

Biotech Boomlet Set To Smash IPO Record For Two-Week Period

Seeking Alpha

Mon, 02/3/14 - 08:22 am

Trio of IPO setbacks strike sour note at biotech's Wall Street party

Fierce Biotech

Thu, 11/14/13 - 11:06 am

Celladon, Xencor bid for $155M in red-hot IPO market

Fierce Biotech

Fri, 10/11/13 - 09:00 am

Corporate VCs crowd into $43M round for Celladon

Fierce Biotech

Wed, 02/15/12 - 10:51 am

venture capital